Palmar plantar erythrodysesthesia epidemiology and demographics: Difference between revisions
Created page with "{{Palmar plantar erythrodysesthesia}} {{CMG}} ==Overview== '''Palmar plantar erythrodysesthesia''' (PPE) is a swelling and numbness of the hands and feet that occurs with [[ch..." |
|||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
==Epidemiology and demographics== | ==Epidemiology and demographics== | ||
PPE occurs in 6-42% of patients receiving chemotherapy. | PPE occurs in 6-42% of patients receiving chemotherapy. | ||
==References== | ==References== | ||
{{reflist|3}} | {{reflist|3}} | ||
Revision as of 14:59, 17 August 2015
|
Palmar plantar erythrodysesthesia Microchapters |
|
Differentiating Palmar plantar erythrodysesthesia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Palmar plantar erythrodysesthesia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia epidemiology and demographics |
|
FDA on Palmar plantar erythrodysesthesia epidemiology and demographics |
|
CDC on Palmar plantar erythrodysesthesia epidemiology and demographics |
|
Palmar plantar erythrodysesthesia epidemiology and demographics in the news |
|
Blogs on Palmar plantar erythrodysesthesia epidemiology and demographics |
|
Directions to Hospitals Treating Palmar plantar erythrodysesthesia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and demographics
PPE occurs in 6-42% of patients receiving chemotherapy.